Hikma and Celltrion sign exclusive licensing agreement for YuflymaTM for the Middle East and North Africa region 2 min read People and Community Hikma and Celltrion sign exclusive licensing agreement for YuflymaTM for the Middle East and North Africa region AETOSWire July 18, 2022 London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces an exclusive licensing agreement...Read More
